Net Income (Loss) Attributable to Parent in USD of BIO-RAD LABORATORIES, INC. from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2010 to Q3 2025.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$342M, a 152% decline year-over-year.
  • Bio Rad Laboratories, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$676M, a 13.2% increase year-over-year.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$1.84B, a 189% decline from 2023.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$637M, a 82.4% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.63B, a 185% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$676M -$342M -$995M -152% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $319M $318M +$2.48B 01 Apr 2025 30 Jun 2025 10-Q 29 Oct 2025
Q1 2025 -$2.16B $64M -$320M -83.3% 01 Jan 2025 31 Mar 2025 10-Q 29 Oct 2025
Q4 2024 -$1.84B -$716M -$1.07B -305% 01 Oct 2024 31 Dec 2024 10-K 14 Feb 2025
Q3 2024 -$779M $653M +$547M +514% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 -$1.33B -$2.17B -$1B -86.3% 01 Apr 2024 30 Jun 2024 10-Q 29 Oct 2025
Q1 2024 -$322M $384M +$315M +456% 01 Jan 2024 31 Mar 2024 10-Q 29 Oct 2025
Q4 2023 -$637M $350M -$478M -57.8% 01 Oct 2023 31 Dec 2023 10-K 14 Feb 2025
Q3 2023 -$159M $106M +$269M 01 Jul 2023 30 Sep 2023 10-K 14 Feb 2025
Q2 2023 -$428M -$1.16B -$237M -25.6% 01 Apr 2023 30 Jun 2023 10-K 14 Feb 2025
Q1 2023 -$191M $69M +$3.44B 01 Jan 2023 31 Mar 2023 10-K 14 Feb 2025
Q4 2022 -$3.63B $828M +$2.4B 01 Oct 2022 31 Dec 2022 10-K 16 Feb 2024
Q3 2022 -$6.03B -$163M -$4.09B -104% 01 Jul 2022 30 Sep 2022 10-K 16 Feb 2024
Q2 2022 -$1.94B -$925M -$1.84B -201% 01 Apr 2022 30 Jun 2022 10-K 16 Feb 2024
Q1 2022 -$93.1M -$3.37B -$4.35B -444% 01 Jan 2022 31 Mar 2022 10-K 16 Feb 2024
Q4 2021 $4.25B -$1.57B -$2.41B -287% 01 Oct 2021 31 Dec 2021 10-K 17 Feb 2023
Q3 2021 $6.67B $3.93B +$2.61B +199% 01 Jul 2021 30 Sep 2021 10-K 17 Feb 2023
Q2 2021 $4.05B $917M -$49.6M -5.13% 01 Apr 2021 30 Jun 2021 10-K 17 Feb 2023
Q1 2021 $4.1B $980M +$294M +42.9% 01 Jan 2021 31 Mar 2021 10-K 17 Feb 2023
Q4 2020 $3.81B $839M +$286M +51.6% 01 Oct 2020 31 Dec 2020 10-K 11 Feb 2022
Q3 2020 $3.52B $1.31B +$1.57B 01 Jul 2020 30 Sep 2020 10-K 11 Feb 2022
Q2 2020 $1.95B $966M +$368M +61.4% 01 Apr 2020 30 Jun 2020 10-K 11 Feb 2022
Q1 2020 $1.58B $686M -$179M -20.7% 01 Jan 2020 31 Mar 2020 10-K 11 Feb 2022
Q4 2019 $1.76B $554M +$1.38B 01 Oct 2019 31 Dec 2019 10-K 16 Feb 2021
Q3 2019 $377M -$259M -$528M -196% 01 Jul 2019 30 Sep 2019 10-K 16 Feb 2021
Q2 2019 $905M $599M +$331M +123% 01 Apr 2019 30 Jun 2019 10-K 16 Feb 2021
Q1 2019 $574M $865M +$208M +31.7% 01 Jan 2019 31 Mar 2019 10-K 16 Feb 2021
Q4 2018 $366M -$829M -$911M -1102% 01 Oct 2018 31 Dec 2018 10-K 02 Mar 2020
Q3 2018 $1.28B $269M +$247M +1119% 01 Jul 2018 30 Sep 2018 10-K 02 Mar 2020
Q2 2018 $1.03B $268M +$263M +5260% 01 Apr 2018 30 Jun 2018 10-K 02 Mar 2020
Q1 2018 $767M $657M +$644M +5197% 01 Jan 2018 31 Mar 2018 10-K 02 Mar 2020
Q4 2017 $122M $82.7M +$101M 01 Oct 2017 31 Dec 2017 10-K 01 Apr 2019
Q3 2017 $20.8M $22.1M +$5M +29.2% 01 Jul 2017 30 Sep 2017 10-K 01 Apr 2019
Q2 2017 $15.8M $5M -$11.6M -69.9% 01 Apr 2017 30 Jun 2017 10-K 01 Apr 2019
Q1 2017 $27.4M $12.4M +$1.4M +12.7% 01 Jan 2017 31 Mar 2017 10-K 01 Apr 2019
Q4 2016 $26M -$18.7M -$68.2M -138% 01 Oct 2016 31 Dec 2016 10-K 16 Apr 2018
Q3 2016 $94.2M $17.1M -$300K -1.72% 01 Jul 2016 30 Sep 2016 10-K 16 Apr 2018
Q2 2016 $94.5M $16.6M -$11.8M -41.5% 01 Apr 2016 30 Jun 2016 10-K 16 Apr 2018
Q1 2016 $106M $11M -$6.8M -38.2% 01 Jan 2016 31 Mar 2016 10-K 16 Apr 2018
Q4 2015 $113M $49.5M +$10.5M +26.9% 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2017
Q3 2015 $103M $17.4M +$5.9M +51.3% 01 Jul 2015 30 Sep 2015 10-K 01 Mar 2017
Q2 2015 $96.7M $28.4M -$3.2M -10.1% 01 Apr 2015 30 Jun 2015 10-K 01 Mar 2017
Q1 2015 $99.9M $17.8M +$11.1M +166% 01 Jan 2015 31 Mar 2015 10-K 01 Mar 2017
Q4 2014 $88.8M $39M +$8.9M +29.6% 01 Oct 2014 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 $79.9M $11.5M +$18.6M 01 Jul 2014 30 Sep 2014 10-K 29 Feb 2016
Q2 2014 $61.3M $31.6M -$3M -8.67% 01 Apr 2014 30 Jun 2014 10-K 29 Feb 2016
Q1 2014 $64.3M $6.7M -$13.5M -66.8% 01 Jan 2014 31 Mar 2014 10-K 29 Feb 2016
Q4 2013 $77.8M $30.1M -$11.9M -28.3% 01 Oct 2013 31 Dec 2013 10-K 02 Mar 2015
Q3 2013 $89.7M -$7.1M -$49.7M -117% 01 Jul 2013 30 Sep 2013 10-K 02 Mar 2015
Q2 2013 $139M $34.6M -$13.7M -28.4% 01 Apr 2013 30 Jun 2013 10-K 02 Mar 2015
Q1 2013 $153M $20.2M -$10.8M -34.8% 01 Jan 2013 31 Mar 2013 10-K 02 Mar 2015
Q4 2012 $164M $42M -$17.2M -29.1% 01 Oct 2012 31 Dec 2012 10-K 18 Mar 2013
Q3 2012 $181M $42.6M -$3.27M -7.12% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $184M $48.3M +$8.34M +20.9% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013
Q1 2012 $176M $31M -$2M -6.05% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 $178M $59.2M -$8.7M -12.8% 01 Oct 2011 31 Dec 2011 10-K 18 Mar 2013
Q3 2011 $187M $45.9M +$1.1M +2.46% 01 Jul 2011 30 Sep 2011 10-K 18 Mar 2013
Q2 2011 $186M $40M +$2M +5.26% 01 Apr 2011 30 Jun 2011 10-K 18 Mar 2013
Q1 2011 $184M $33M -$1.9M -5.44% 01 Jan 2011 31 Mar 2011 10-K 18 Mar 2013
Q4 2010 $186M $67.9M 01 Oct 2010 31 Dec 2010 10-K 29 Feb 2012
Q3 2010 $44.8M 01 Jul 2010 30 Sep 2010 10-K 29 Feb 2012
Q2 2010 $38M 01 Apr 2010 30 Jun 2010 10-K 29 Feb 2012
Q1 2010 $34.9M 01 Jan 2010 31 Mar 2010 10-K 29 Feb 2012

BIO-RAD LABORATORIES, INC. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.84B -$1.21B -189% 01 Jan 2024 31 Dec 2024 10-K 14 Feb 2025
2023 -$637M +$2.99B +82.4% 01 Jan 2023 31 Dec 2023 10-K 14 Feb 2025
2022 -$3.63B -$7.88B -185% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025
2021 $4.25B +$440M +11.5% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024
2020 $3.81B +$2.06B +117% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023
2019 $1.76B +$1.39B +381% 01 Jan 2019 31 Dec 2019 10-K 11 Feb 2022
2018 $366M +$243M +199% 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021
2017 $122M +$96.2M +370% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020
2016 $26M -$83.2M -76.2% 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019
2015 $109M +$20.4M +23% 01 Jan 2015 31 Dec 2015 10-K 16 Apr 2018
2014 $88.8M +$11.1M +14.2% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017
2013 $77.8M -$87.7M -53% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016
2012 $165M -$13.5M -7.56% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015
2011 $179M -$6.48M -3.49% 01 Jan 2011 31 Dec 2011 10-K 18 Mar 2014
2010 $185M 01 Jan 2010 31 Dec 2010 10-K 18 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.